Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy

Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of anesthesia 2015-04, Vol.29 (2), p.191-197
Hauptverfasser: Kang, Mae-Hwa, Lee, Ho-Jin, Lim, Young-Jin, Jeon, Young-Tae, Hwang, Jung-Won, Park, Hee-Pyoung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 197
container_issue 2
container_start_page 191
container_title Journal of anesthesia
container_volume 29
creator Kang, Mae-Hwa
Lee, Ho-Jin
Lim, Young-Jin
Jeon, Young-Tae
Hwang, Jung-Won
Park, Hee-Pyoung
description Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated hemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain hemodynamic stability during hydrodissection. Methods Forty-one patients undergoing robot-assisted endoscopic thyroidectomy were randomly allocated to one of the two groups—group D ( n  = 22) and group C ( n  = 19) patients received dexmedetomidine 1 µg/kg and normal saline for 10 min before anesthetic induction, respectively. The EC50 of remifentanil for hemodynamic stability during hydrodissection was determined using Dixon’s up-and-down method with initial dose (4 and 5 ng/mL in groups D and C, respectively). The concentration of remifentanil for consecutive patients in each group was determined by the response of the previous patient, using increments or decrements of 0.5 ng/mL. Hemodynamic stability during hydrodissection was defined as increased systolic blood pressure
doi_str_mv 10.1007/s00540-014-1923-6
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1672606286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A432511300</galeid><sourcerecordid>A432511300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-5cf969c6b417d1a156ed3f84577b615b55fcb63a15974622c09903cd009d8f9a3</originalsourceid><addsrcrecordid>eNp9kU2L1TAYhYMozp3RH-BGCm7cdMxHkzbLYfBjYEAXug5p8rY3Q5vUJBW78L-bS0dBuEgWgfd9ziE5B6FXBF8TjNt3CWPe4BqTpiaSslo8QQfSsK7uGJdP0QFLwupOiO4CXab0gDEWhLDn6IJyKmjT8gP69SVCWCDq7H5AZeHnDBZymJ11HiqdM_hVZ0jVEeZgN69nZ6oIaQk-lWkO1XGzMViXEpjsgq-cr5biBj6navUW4hicH6sY-pCLNh-3GJwtcJi3F-jZoKcELx_vK_Ttw_uvt5_q-88f725v7mvDG5ZrbgYppBF9Q1pLNOECLBu6hrdtLwjvOR9ML1hZyLYRlBosJWbGYixtN0jNrtDb3XeJ4fsKKavZJQPTpD2ENSkiWiqwoJ0o6JsdHfUEyvkh5KjNCVc3DaO8BIhxoeoz1Ai-JDkFD4Mr43_46zN8ORZKoGcFZBeYGFKKMKglulnHTRGsTuWrvXxVylen8tXp6a8ff7n2pca_ij9tF4DuQCorP0JUD2GNviT_H9ffNGi7eg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672606286</pqid></control><display><type>article</type><title>Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kang, Mae-Hwa ; Lee, Ho-Jin ; Lim, Young-Jin ; Jeon, Young-Tae ; Hwang, Jung-Won ; Park, Hee-Pyoung</creator><creatorcontrib>Kang, Mae-Hwa ; Lee, Ho-Jin ; Lim, Young-Jin ; Jeon, Young-Tae ; Hwang, Jung-Won ; Park, Hee-Pyoung</creatorcontrib><description>Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated hemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain hemodynamic stability during hydrodissection. Methods Forty-one patients undergoing robot-assisted endoscopic thyroidectomy were randomly allocated to one of the two groups—group D ( n  = 22) and group C ( n  = 19) patients received dexmedetomidine 1 µg/kg and normal saline for 10 min before anesthetic induction, respectively. The EC50 of remifentanil for hemodynamic stability during hydrodissection was determined using Dixon’s up-and-down method with initial dose (4 and 5 ng/mL in groups D and C, respectively). The concentration of remifentanil for consecutive patients in each group was determined by the response of the previous patient, using increments or decrements of 0.5 ng/mL. Hemodynamic stability during hydrodissection was defined as increased systolic blood pressure &lt;20 % of baseline. Results The EC50 of remifentanil for maintaining hemodynamic stability during hydrodissection was 0.8 ng/mL in group D and 7.3 ng/mL in group C ( p  = 0.002). Conclusions A single preoperative dexmedetomidine injection attenuated hydrodissection-induced hemodynamic responses in patients undergoing robotic thyroidectomy.</description><identifier>ISSN: 0913-8668</identifier><identifier>EISSN: 1438-8359</identifier><identifier>DOI: 10.1007/s00540-014-1923-6</identifier><identifier>PMID: 25262475</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Adrenergic alpha-2 Receptor Agonists - therapeutic use ; Adult ; Analgesia ; Anesthesia, Intravenous - adverse effects ; Anesthesia, Intravenous - methods ; Anesthesiology ; Anesthetics, Intravenous ; Critical Care Medicine ; Development and progression ; Dexmedetomidine ; Dexmedetomidine - therapeutic use ; Double-Blind Method ; Emergency Medicine ; Female ; Heart rate ; Hemodynamics - drug effects ; Humans ; Intensive ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Original Article ; Pain Medicine ; Perioperative Care - methods ; Piperidines ; Propofol ; Prospective Studies ; Risk factors ; Robotics ; Thyroidectomy - adverse effects ; Young Adult</subject><ispartof>Journal of anesthesia, 2015-04, Vol.29 (2), p.191-197</ispartof><rights>Japanese Society of Anesthesiologists 2014</rights><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-5cf969c6b417d1a156ed3f84577b615b55fcb63a15974622c09903cd009d8f9a3</citedby><cites>FETCH-LOGICAL-c543t-5cf969c6b417d1a156ed3f84577b615b55fcb63a15974622c09903cd009d8f9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00540-014-1923-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00540-014-1923-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25262475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kang, Mae-Hwa</creatorcontrib><creatorcontrib>Lee, Ho-Jin</creatorcontrib><creatorcontrib>Lim, Young-Jin</creatorcontrib><creatorcontrib>Jeon, Young-Tae</creatorcontrib><creatorcontrib>Hwang, Jung-Won</creatorcontrib><creatorcontrib>Park, Hee-Pyoung</creatorcontrib><title>Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy</title><title>Journal of anesthesia</title><addtitle>J Anesth</addtitle><addtitle>J Anesth</addtitle><description>Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated hemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain hemodynamic stability during hydrodissection. Methods Forty-one patients undergoing robot-assisted endoscopic thyroidectomy were randomly allocated to one of the two groups—group D ( n  = 22) and group C ( n  = 19) patients received dexmedetomidine 1 µg/kg and normal saline for 10 min before anesthetic induction, respectively. The EC50 of remifentanil for hemodynamic stability during hydrodissection was determined using Dixon’s up-and-down method with initial dose (4 and 5 ng/mL in groups D and C, respectively). The concentration of remifentanil for consecutive patients in each group was determined by the response of the previous patient, using increments or decrements of 0.5 ng/mL. Hemodynamic stability during hydrodissection was defined as increased systolic blood pressure &lt;20 % of baseline. Results The EC50 of remifentanil for maintaining hemodynamic stability during hydrodissection was 0.8 ng/mL in group D and 7.3 ng/mL in group C ( p  = 0.002). Conclusions A single preoperative dexmedetomidine injection attenuated hydrodissection-induced hemodynamic responses in patients undergoing robotic thyroidectomy.</description><subject>Adrenergic alpha-2 Receptor Agonists - therapeutic use</subject><subject>Adult</subject><subject>Analgesia</subject><subject>Anesthesia, Intravenous - adverse effects</subject><subject>Anesthesia, Intravenous - methods</subject><subject>Anesthesiology</subject><subject>Anesthetics, Intravenous</subject><subject>Critical Care Medicine</subject><subject>Development and progression</subject><subject>Dexmedetomidine</subject><subject>Dexmedetomidine - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Emergency Medicine</subject><subject>Female</subject><subject>Heart rate</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Intensive</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Perioperative Care - methods</subject><subject>Piperidines</subject><subject>Propofol</subject><subject>Prospective Studies</subject><subject>Risk factors</subject><subject>Robotics</subject><subject>Thyroidectomy - adverse effects</subject><subject>Young Adult</subject><issn>0913-8668</issn><issn>1438-8359</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L1TAYhYMozp3RH-BGCm7cdMxHkzbLYfBjYEAXug5p8rY3Q5vUJBW78L-bS0dBuEgWgfd9ziE5B6FXBF8TjNt3CWPe4BqTpiaSslo8QQfSsK7uGJdP0QFLwupOiO4CXab0gDEWhLDn6IJyKmjT8gP69SVCWCDq7H5AZeHnDBZymJ11HiqdM_hVZ0jVEeZgN69nZ6oIaQk-lWkO1XGzMViXEpjsgq-cr5biBj6navUW4hicH6sY-pCLNh-3GJwtcJi3F-jZoKcELx_vK_Ttw_uvt5_q-88f725v7mvDG5ZrbgYppBF9Q1pLNOECLBu6hrdtLwjvOR9ML1hZyLYRlBosJWbGYixtN0jNrtDb3XeJ4fsKKavZJQPTpD2ENSkiWiqwoJ0o6JsdHfUEyvkh5KjNCVc3DaO8BIhxoeoz1Ai-JDkFD4Mr43_46zN8ORZKoGcFZBeYGFKKMKglulnHTRGsTuWrvXxVylen8tXp6a8ff7n2pca_ij9tF4DuQCorP0JUD2GNviT_H9ffNGi7eg</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Kang, Mae-Hwa</creator><creator>Lee, Ho-Jin</creator><creator>Lim, Young-Jin</creator><creator>Jeon, Young-Tae</creator><creator>Hwang, Jung-Won</creator><creator>Park, Hee-Pyoung</creator><general>Springer Japan</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy</title><author>Kang, Mae-Hwa ; Lee, Ho-Jin ; Lim, Young-Jin ; Jeon, Young-Tae ; Hwang, Jung-Won ; Park, Hee-Pyoung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-5cf969c6b417d1a156ed3f84577b615b55fcb63a15974622c09903cd009d8f9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adrenergic alpha-2 Receptor Agonists - therapeutic use</topic><topic>Adult</topic><topic>Analgesia</topic><topic>Anesthesia, Intravenous - adverse effects</topic><topic>Anesthesia, Intravenous - methods</topic><topic>Anesthesiology</topic><topic>Anesthetics, Intravenous</topic><topic>Critical Care Medicine</topic><topic>Development and progression</topic><topic>Dexmedetomidine</topic><topic>Dexmedetomidine - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Emergency Medicine</topic><topic>Female</topic><topic>Heart rate</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Intensive</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Perioperative Care - methods</topic><topic>Piperidines</topic><topic>Propofol</topic><topic>Prospective Studies</topic><topic>Risk factors</topic><topic>Robotics</topic><topic>Thyroidectomy - adverse effects</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kang, Mae-Hwa</creatorcontrib><creatorcontrib>Lee, Ho-Jin</creatorcontrib><creatorcontrib>Lim, Young-Jin</creatorcontrib><creatorcontrib>Jeon, Young-Tae</creatorcontrib><creatorcontrib>Hwang, Jung-Won</creatorcontrib><creatorcontrib>Park, Hee-Pyoung</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, Mae-Hwa</au><au>Lee, Ho-Jin</au><au>Lim, Young-Jin</au><au>Jeon, Young-Tae</au><au>Hwang, Jung-Won</au><au>Park, Hee-Pyoung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy</atitle><jtitle>Journal of anesthesia</jtitle><stitle>J Anesth</stitle><addtitle>J Anesth</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>29</volume><issue>2</issue><spage>191</spage><epage>197</epage><pages>191-197</pages><issn>0913-8668</issn><eissn>1438-8359</eissn><abstract>Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated hemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain hemodynamic stability during hydrodissection. Methods Forty-one patients undergoing robot-assisted endoscopic thyroidectomy were randomly allocated to one of the two groups—group D ( n  = 22) and group C ( n  = 19) patients received dexmedetomidine 1 µg/kg and normal saline for 10 min before anesthetic induction, respectively. The EC50 of remifentanil for hemodynamic stability during hydrodissection was determined using Dixon’s up-and-down method with initial dose (4 and 5 ng/mL in groups D and C, respectively). The concentration of remifentanil for consecutive patients in each group was determined by the response of the previous patient, using increments or decrements of 0.5 ng/mL. Hemodynamic stability during hydrodissection was defined as increased systolic blood pressure &lt;20 % of baseline. Results The EC50 of remifentanil for maintaining hemodynamic stability during hydrodissection was 0.8 ng/mL in group D and 7.3 ng/mL in group C ( p  = 0.002). Conclusions A single preoperative dexmedetomidine injection attenuated hydrodissection-induced hemodynamic responses in patients undergoing robotic thyroidectomy.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>25262475</pmid><doi>10.1007/s00540-014-1923-6</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0913-8668
ispartof Journal of anesthesia, 2015-04, Vol.29 (2), p.191-197
issn 0913-8668
1438-8359
language eng
recordid cdi_proquest_miscellaneous_1672606286
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adrenergic alpha-2 Receptor Agonists - therapeutic use
Adult
Analgesia
Anesthesia, Intravenous - adverse effects
Anesthesia, Intravenous - methods
Anesthesiology
Anesthetics, Intravenous
Critical Care Medicine
Development and progression
Dexmedetomidine
Dexmedetomidine - therapeutic use
Double-Blind Method
Emergency Medicine
Female
Heart rate
Hemodynamics - drug effects
Humans
Intensive
Male
Medicine
Medicine & Public Health
Middle Aged
Original Article
Pain Medicine
Perioperative Care - methods
Piperidines
Propofol
Prospective Studies
Risk factors
Robotics
Thyroidectomy - adverse effects
Young Adult
title Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preoperative%20dexmedetomidine%20attenuates%20hemodynamic%20responses%20to%20hydrodissection%20in%20patients%20undergoing%20robotic%20thyroidectomy&rft.jtitle=Journal%20of%20anesthesia&rft.au=Kang,%20Mae-Hwa&rft.date=2015-04-01&rft.volume=29&rft.issue=2&rft.spage=191&rft.epage=197&rft.pages=191-197&rft.issn=0913-8668&rft.eissn=1438-8359&rft_id=info:doi/10.1007/s00540-014-1923-6&rft_dat=%3Cgale_proqu%3EA432511300%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1672606286&rft_id=info:pmid/25262475&rft_galeid=A432511300&rfr_iscdi=true